AC Immune’s Phase II trial showed an increase in anti-a-syn antibodies following treatment with the Parkinson’s disease ...

Licensed SYN-2510, a potential best-in-class PD-L1xVEGF bispecific antibody, for global ex-China development and commercialization Clinical data update for SYN-2510/IMM2510 in China from ImmuneOnco ...

Dragon Ball Sparking Zero features Syn Shenron as a playable character, the ultimate antagonist of Dragon Ball GT.

A new study aims to better understand Parkinson’s disease by tracking quantifiable changes in nerves in the skin over time.

Syn-AKE is a synthetic tripeptide that emulates the active region of Waglerin-1, a venom component derived from the Temple Viper (Tropidolaemus wagleri).